IE913816A1 - Cell growth inhibitors - Google Patents

Cell growth inhibitors

Info

Publication number
IE913816A1
IE913816A1 IE381691A IE381691A IE913816A1 IE 913816 A1 IE913816 A1 IE 913816A1 IE 381691 A IE381691 A IE 381691A IE 381691 A IE381691 A IE 381691A IE 913816 A1 IE913816 A1 IE 913816A1
Authority
IE
Ireland
Prior art keywords
protein
agglutinating
gbp
cells
binding protein
Prior art date
Application number
IE381691A
Other languages
English (en)
Other versions
IE83449B1 (en
Inventor
Mallucci Livio
Wells Valerie
Original Assignee
Mallucci Livio
Wells Valerie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of IE83449B1 publication Critical patent/IE83449B1/en
Application filed by Mallucci Livio, Wells Valerie filed Critical Mallucci Livio
Publication of IE913816A1 publication Critical patent/IE913816A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE381691A 1990-11-02 1991-10-31 Cell growth inhibitors IE913816A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBUNITEDKINGDOM02/11/19909023907.0
GB909023907A GB9023907D0 (en) 1990-11-02 1990-11-02 Cell growth inhibitors

Publications (2)

Publication Number Publication Date
IE83449B1 IE83449B1 (en)
IE913816A1 true IE913816A1 (en) 1992-05-22

Family

ID=10684796

Family Applications (1)

Application Number Title Priority Date Filing Date
IE381691A IE913816A1 (en) 1990-11-02 1991-10-31 Cell growth inhibitors

Country Status (11)

Country Link
US (1) US6127169A (de)
EP (1) EP0555286B1 (de)
JP (1) JP3497504B2 (de)
AT (1) ATE204018T1 (de)
AU (1) AU650066B2 (de)
CA (1) CA2095335C (de)
DE (1) DE69132682T2 (de)
GB (2) GB9023907D0 (de)
IE (1) IE913816A1 (de)
IL (1) IL99940A0 (de)
WO (1) WO1992007938A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916871A (en) * 1992-04-27 1999-06-29 Kansas State University Research Foundation Inhibitory factor
JPH07508878A (ja) * 1992-04-27 1995-10-05 カンザス ステイト ユニバーシティ リサーチ ファウンデーション 阻害因子
AU9301998A (en) * 1997-09-05 1999-03-22 Board Of Regents Of The University Of Oklahoma, The Composition and methods using galectin-1
US5948628A (en) 1997-09-05 1999-09-07 The Board Of Regents Of The University Of Oklahoma Methods of screening for compounds which mimic galectin-1
JP2002322082A (ja) * 2001-04-26 2002-11-08 Purotejiin:Kk 腎炎の予防・治療剤
GB2450146A (en) * 2007-06-14 2008-12-17 Livio Mallucci ßGBP, compositions comprising ßGBP, and related methods and uses thereof
US7994113B2 (en) * 2007-06-14 2011-08-09 Livio Mallucci βGBP, compositions comprising βGBP, and related methods and uses thereof
EP2167597B1 (de) * 2007-06-15 2013-05-01 Basf Se Voc-arme wässrige hybridbindemittel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63164895A (ja) * 1986-09-13 1988-07-08 Sanwa Kagaku Kenkyusho Co Ltd 培養細胞由来のレクチン様蛋白質及びその製法並びに該物質を主成分とする抗腫瘍剤
WO1989001519A1 (en) * 1987-08-20 1989-02-23 Children's Hospital Corporation Human mannose binding protein
ES2096557T3 (es) * 1988-04-14 1997-03-16 Incyte Pharma Inc Lectinas 14-beta-gal de mamiferos.

Also Published As

Publication number Publication date
GB9023907D0 (en) 1990-12-12
AU8756591A (en) 1992-05-26
US6127169A (en) 2000-10-03
JPH06502302A (ja) 1994-03-17
CA2095335A1 (en) 1992-05-03
EP0555286A1 (de) 1993-08-18
GB9123036D0 (en) 1991-12-18
WO1992007938A1 (en) 1992-05-14
DE69132682T2 (de) 2002-07-04
GB2249312A (en) 1992-05-06
GB2249312B (en) 1994-11-16
IL99940A0 (en) 1992-08-18
EP0555286B1 (de) 2001-08-08
CA2095335C (en) 2002-10-22
AU650066B2 (en) 1994-06-09
DE69132682D1 (de) 2001-09-13
JP3497504B2 (ja) 2004-02-16
ATE204018T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
JP2567114B2 (ja) ヒト血管浸透性因子
DE69637148T2 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
JPH04504105A (ja) フォリスタチンおよびその精製法
US5731167A (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
CA2098397C (en) Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto
US5587460A (en) 14-beta-gal mammalian lectins
JPH05503512A (ja) 白血球接着阻害因子としての［ａｌａ　ｉｌ―８］↓７↓７
US5227302A (en) DNA encoding platelet derived endothelial cell growth factor (PD-ECGF)
IBRAHIM et al. Reproductive tract secretions and bull spermatozoa contain different clusterin isoforms that cluster cells and inhibit complement‐induced cytolysis
EP0555286B1 (de) Zellwachstumsinhibitoren
JPH07258293A (ja) 新規な蛋白質ならびにその製造方法
EP0377855B1 (de) Endothelialzellen-Wachstumsfaktor
IE83449B1 (en) Cell growth inhibitors
US5824551A (en) Method for modulating cell apoptosis
JPH04504262A (ja) 内皮細胞成長因子、その分離および発現
US5728548A (en) Retinoid receptor-1 (RR1) and DNA encoding RR1
US5837239A (en) Physiologically active substance designated as epimorphin genes encoding the same and antibodies thereto
US7939635B2 (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
JPH07138296A (ja) Ｃｓｖｔｃｇ特異的腫瘍細胞の接着受容体の精製及び特性付け
EP3649159B1 (de) Fusionsprotein
US5756686A (en) Peptides derived from endothelial cell growth factor
AU711011B2 (en) Method for modulating cell apoptosis
JPH06293800A (ja) 新規生理活性物質エピモルフィン、それをコードする 遺伝子及びエピモルフィンに対する抗体
JP2003021632A (ja) ウロキナーゼレセプターに対する抗体とその用途
JPH07135994A (ja) 抗体、ポリペプチド、その製造法および用途